Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebral bypass perfusion: dobutamine versus phenylephrine pilot study
2018-002008-15Phase 4Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dobutamine and phenylephrine in brain ischemia, Moyamoya disease, Carotid artery occlusion (CAO) and 1 more, sponsored by University Medical Center Utrecht. Primary endpoints: Mean change in graft flow rate with dobutamine and Mean change in graft flow rate with phenylephrine. Started Jun 2018; status: completed.
02
Drugs
dobutaminephenylephrine
03
Conditions
brain ischemiaMoyamoya diseaseCarotid artery occlusion (CAO)brain aneurysm (IA)
Beyond the preview
Go deeper on 2018-002008-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002008-15.